Literature DB >> 12063046

A novel mutation of the OPA1 gene in a Japanese family with optic atrophy type 1.

Satoko Shimizu1, Naoki Mori, Mari Kishi, Hirohisa Sugata, Akiko Tsuda, Nobue Kubota.   

Abstract

PURPOSE: To report a novel mutation of the OPA1 gene in a Japanese family with optic atrophy type 1 (OPA1) and to describe the clinical features of this family.
METHODS: Standard ocular examinations were performed on the proband and his two affected sons. The DNA sequence of all exons and splice sites of the OPA1 gene was determined to detect mutations.
RESULTS: The proband and his sons had a heterozygous mutation of the OPA1 gene in the third nucleotide of intron 12 (IVS12+3A-->T). Clinically, each patient had reduced visual acuity (onset within the first 6 years of life) and optic nerve pallor. The proband showed bilateral central scotomas and generalized dyschroatopsia. This is the first report of OPA1 gene mutation in Japanese patients with familial optic atrophy.
CONCLUSIONS: A mutation of the OPA1 gene was detected in a Japanese family with OPA1, which follows the same pattern as reported in Western countries. It is suggested that mutations of the OPA1 gene contribute to the development of optic nerve atrophy regardless of ethnic groups. Screening for the OPA1 gene mutation will be useful for diagnosis of OPA1 in Japanese patients.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12063046     DOI: 10.1016/s0021-5155(02)00484-7

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  2 in total

1.  A novel mutation producing premature termination codon at the OPA1 gene causes autosomal dominant optic atrophy.

Authors:  Elena Cardaioli; Gian Nicola Gallus; Paola Da Pozzo; Alessandra Rufa; Rossella Franceschini; Eduardo Motolese; Aldo Caporossi; Maria T Dotti; Antonio Federico
Journal:  J Neurol       Date:  2005-12-12       Impact factor: 4.849

2.  Heterozygous deletion of the OPA1 gene in patients with dominant optic atrophy.

Authors:  Takaaki Hayashi; Hiroyuki Sasano; Satoshi Katagiri; Kazushige Tsunoda; Shuhei Kameya; Mitsuru Nakazawa; Takeshi Iwata; Hiroshi Tsuneoka
Journal:  Jpn J Ophthalmol       Date:  2017-07-01       Impact factor: 2.447

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.